葛兰素史克GSK-201409-ERSInvestor&AnaystEvent-sides

ERSInvestor&AnalystEventMunichTuesday9thSeptember2014DarrellBakerSVP,GlobalHeadofRespiratoryAgenda3GSK’sRespiratoryPortfolioDarrellBaker,GlobalHeadofRespiratoryatGSK13:45–14:00EosinophilsResearchinCOPDProfessorNeilBarnes,RespiratoryFranchiseMedicalHeadatGSK14:00–14:10Eosinophils–ClinicalExperienceinSevereAsthmaProfessorIanPavord,UniversityofOxford14:10–14:25MepolizumabPhaseIIIdatainSevereAsthmaStevenYancey,MedicineDevelopmentLeaderatGSK14:25–14:45Q&A14:45–15:45Respiratoryportfoliointransition–newportfolioprovidesplatformforcontinuedmarketleadership4BreoElliptaapproved&launchedAnoroElliptaapproved&launchedIncruseElliptaapprovedArnuityElliptaapproved5additionalproductsinlatestagedevelopment?mepolizumab?ICS/LABA/LAMA(closedtriple)?VImonotherapy?ICS/LAMA?MABA